Phipps W, Kilgore M, Kennedy J, Whiteaker J, Hoofnagle A, Paulovich A
Mol Cell Proteomics. 2023; 22(11):100648.
PMID: 37730181
PMC: 10692389.
DOI: 10.1016/j.mcpro.2023.100648.
Fang C, Huang X, Dai J, He W, Xu L, Sun F
BMC Cancer. 2022; 22(1):373.
PMID: 35395756
PMC: 8991568.
DOI: 10.1186/s12885-022-09467-7.
Song Q, Seigne J, Schned A, Kelsey K, Karagas M, Hassanpour S
AMIA Jt Summits Transl Sci Proc. 2020; 2020:607-616.
PMID: 32477683
PMC: 7233061.
Braunhut B, Graham A, Lian F, Webster P, Krupinski E, Bhattacharyya A
J Pathol Inform. 2014; 5(1):18.
PMID: 25057432
PMC: 4060405.
DOI: 10.4103/2153-3539.133142.
Lyle S, Hsieh C, Fernandez C, Shuber A
Res Rep Urol. 2013; 4:65-9.
PMID: 24199183
PMC: 3806446.
DOI: 10.2147/RRU.S37355.
Accuracy of grading of urothelial carcinoma on urine cytology: an analysis of interobserver and intraobserver agreement.
Reid M, Osunkoya A, Siddiqui M, Looney S
Int J Clin Exp Pathol. 2012; 5(9):882-91.
PMID: 23119105
PMC: 3484494.
Histologic grading of urothelial papillary neoplasms: impact of combined grading (two-numbered grading system) on reproducibility.
Tuna B, Yorukoglu K, Duzcan E, Sen S, Nese N, Sarsik B
Virchows Arch. 2011; 458(6):659-64.
PMID: 21484429
DOI: 10.1007/s00428-011-1072-3.
Vascular endothelial growth factor, p53, and the H-ras oncogene in Egyptian patients with bladder cancer.
El-Chennawi F, Auf F, Metwally S, Mosaad Y, Shaaban A, El-Baz M
World J Gastrointest Oncol. 2010; 1(1):62-8.
PMID: 21160776
PMC: 2999101.
DOI: 10.4251/wjgo.v1.i1.62.
Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target.
Knowles M
World J Urol. 2007; 25(6):581-93.
PMID: 17912529
PMC: 4876910.
DOI: 10.1007/s00345-007-0213-4.
Reproducibility and reliability of tumor grading in urological neoplasms.
Engers R
World J Urol. 2007; 25(6):595-605.
PMID: 17828603
DOI: 10.1007/s00345-007-0209-0.
Proliferating cell nuclear antigen (PCNA) overexpression and microvessel density predict survival in the urinary bladder carcinoma.
El-Kott A, El-Baz M, Mokhtar A
Int Urol Nephrol. 2006; 38(2):237-42.
PMID: 16868689
DOI: 10.1007/s11255-005-4760-6.
Comparison of the nuclear matrix protein 22 with voided urine cytology in the diagnosis of transitional cell carcinoma of the bladder.
Lekili M, Sener E, Demir M, Temeltas G, Muezzinoglu T, Buyuksu C
Urol Res. 2003; 32(2):124-8.
PMID: 14685796
DOI: 10.1007/s00240-003-0394-2.
Reproducibility of the 1998 World Health Organization/International Society of Urologic Pathology classification of papillary urothelial neoplasms of the urinary bladder.
Yorukoglu K, Tuna B, Dikicioglu E, Duzcan E, Isisag A, Sen S
Virchows Arch. 2003; 443(6):734-40.
PMID: 14534785
DOI: 10.1007/s00428-003-0905-0.
Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer. Finnbladder III Group.
Liukkonen T, Lipponen P, Helle M, Jauhiainen K
Urol Res. 1997; 25(1):1-7.
PMID: 9079739
DOI: 10.1007/BF00941899.
Expression of MIB-1, mitotic index and S-phase fraction as indicators of cell proliferation in superficial bladder cancer. Finnbladder Group.
Liukkonen T, Lipponen P, Helle M, Haapasalo H, Nordling S, Rajala P
Urol Res. 1996; 24(1):61-6.
PMID: 8966844
DOI: 10.1007/BF00296736.
Lamina propria microinvasion of bladder tumors, incidence on stage allocation (pTa vs pT1): recommended approach. Pathologists of the French Association of Urology Cancer Committee.
World J Urol. 1993; 11(3):161-4.
PMID: 8401635
DOI: 10.1007/BF00211412.
Prognostic factors in superficial bladder cancer.
Chopin D, Popov Z, Ravery V, Bellot J, Hoznek A, Patard J
World J Urol. 1993; 11(3):148-52.
PMID: 8401632
DOI: 10.1007/BF00211409.
Superficial bladder carcinoma. Factors affecting the natural history.
Fitzpatrick J
World J Urol. 1993; 11(3):142-7.
PMID: 8401631
DOI: 10.1007/BF00211408.
The value of tumour spread, grading and growth pattern as morphological predictive parameters in bladder carcinoma. A critical revision of the 1987 TNM classification.
Angulo J, Lopez J, Flores N, Toledo J
J Cancer Res Clin Oncol. 1993; 119(10):578-93.
PMID: 8335677
DOI: 10.1007/BF01372721.
Cell proliferation indices, morphometry and DNA flow cytometry provide objective criteria for distinguishing low and high grade bladder carcinomas.
Pich A, Chiusa L, Comino A, Navone R
Virchows Arch. 1994; 424(2):143-8.
PMID: 7910097
DOI: 10.1007/BF00193493.